abstract |
The invention provides nicotinic acid II with immunosuppressive activity, which has a structural formula as follows: the nicotinic acid compound provided by the invention has good immunosuppressive activity and platelet aggregation inhibition activity, is strong in selectivity, and has good clinical application value. |